Xiaxia Wu

820 total citations · 1 hit paper
16 papers, 629 citations indexed

About

Xiaxia Wu is a scholar working on Molecular Biology, Complementary and alternative medicine and Infectious Diseases. According to data from OpenAlex, Xiaxia Wu has authored 16 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Complementary and alternative medicine and 2 papers in Infectious Diseases. Recurrent topics in Xiaxia Wu's work include Natural product bioactivities and synthesis (4 papers), Traditional Chinese Medicine Analysis (3 papers) and COVID-19 Clinical Research Studies (2 papers). Xiaxia Wu is often cited by papers focused on Natural product bioactivities and synthesis (4 papers), Traditional Chinese Medicine Analysis (3 papers) and COVID-19 Clinical Research Studies (2 papers). Xiaxia Wu collaborates with scholars based in China, Macao and United States. Xiaxia Wu's co-authors include Xiuping Chen, Jin‐Jian Lu, Wen Sun, Hongwei Gao, Yue Lü, Ben Niu, Xiuzhi Wang, Aiping Wang, Dongfang Cheng and Changxi Wang and has published in prestigious journals such as Scientific Reports, Free Radical Biology and Medicine and Antioxidants and Redox Signaling.

In The Last Decade

Xiaxia Wu

16 papers receiving 618 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Properties of Poly (Lactic-co-Glycolic Acid) and Progress of Poly (Lactic-co-Glycolic Acid)-Based Biodegradable Materials in Biomedical Research

2023 126 citations Yue Lü, Dongfang Cheng et al. Pharmaceuticals profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaxia Wu China	10	283	84	76	75	73	16	629
Guang Xin China	17	440 1.6×	60 0.7×	124 1.6×	68 0.9×	47 0.6×	54	954
Mariana Deleanu Romania	18	249 0.9×	51 0.6×	138 1.8×	47 0.6×	31 0.4×	34	759
V. M. Berlin Grace India	20	584 2.1×	146 1.7×	83 1.1×	134 1.8×	70 1.0×	59	1.2k
Hassan Dariushnejad Iran	17	453 1.6×	39 0.5×	135 1.8×	126 1.7×	45 0.6×	47	908
Pei-Ying Zhang China	9	214 0.8×	62 0.7×	47 0.6×	60 0.8×	21 0.3×	19	529
Jiaxin Li China	16	310 1.1×	38 0.5×	96 1.3×	189 2.5×	48 0.7×	81	806
Junzhe Zhang China	16	455 1.6×	44 0.5×	110 1.4×	85 1.1×	129 1.8×	53	1.0k
Youness Limami Morocco	18	404 1.4×	25 0.3×	111 1.5×	119 1.6×	48 0.7×	43	1.1k
Ying Xiao China	18	326 1.2×	69 0.8×	40 0.5×	51 0.7×	16 0.2×	65	732
Peng Qiu China	15	330 1.2×	74 0.9×	115 1.5×	54 0.7×	19 0.3×	21	707

Countries citing papers authored by Xiaxia Wu

Since Specialization

Citations

This map shows the geographic impact of Xiaxia Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaxia Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaxia Wu more than expected).

Fields of papers citing papers by Xiaxia Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaxia Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaxia Wu. The network helps show where Xiaxia Wu may publish in the future.

Co-authorship network of co-authors of Xiaxia Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaxia Wu. A scholar is included among the top collaborators of Xiaxia Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaxia Wu. Xiaxia Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Hao, Xiaoting & Xiaxia Wu. (2024). SP1‑mediated ADAMTS5 transcription promotes IL‑1β‑induced chondrocyte injury via Wnt/β‑catenin pathway in osteoarthritis. Molecular Medicine Reports. 30(2). 1 indexed citations

Wu, Xiaxia, et al.. (2024). The quality of life of patients with chronic obstructive pulmonary disease: a bibliometric analysis. Journal of Thoracic Disease. 16(4). 2591–2603. 3 indexed citations

Lü, Yue, Dongfang Cheng, Ben Niu, et al.. (2023). Properties of Poly (Lactic-co-Glycolic Acid) and Progress of Poly (Lactic-co-Glycolic Acid)-Based Biodegradable Materials in Biomedical Research. Pharmaceuticals. 16(3). 454–454. 126 indexed citations breakdown →

Wu, Xiaxia, et al.. (2023). A liquid crystal in situ gel based on rotigotine for the treatment of Parkinson’s disease. Drug Delivery and Translational Research. 14(4). 1048–1062. 4 indexed citations

Li, Dong, Xiaxia Wu, & Shuling Yan. (2023). Periodic traveling wave solutions of the Nicholson's blowflies model with delay and advection. Electronic Research Archive. 31(5). 2568–2579. 1 indexed citations

Wu, Xiaxia & Zhijun Bao. (2021). Population-Based Study of the Clinical Characteristics and Risk Factors of Ischemic Colitis. The Turkish Journal of Gastroenterology. 32(4). 393–400. 4 indexed citations

Wu, Xiaxia, Xiumei Li, Chunmei Xu, et al.. (2021). Prediction and follow-up of risk factors for severe SARS-CoV-2 pneumonia and application of CT visual scoring. Technology and Health Care. 29(S1). 153–164. 2 indexed citations

Yang, Li, et al.. (2020). Chest CT imaging characteristics of COVID-19 pneumonia in preschool children: a retrospective study. BMC Pediatrics. 20(1). 227–227. 25 indexed citations

Wu, Xiaxia, Hongwei Gao, Ying Hou, et al.. (2018). Dihydronortanshinone, a natural product, alleviates LPS-induced inflammatory response through NF-κB, mitochondrial ROS, and MAPK pathways. Toxicology and Applied Pharmacology. 355. 1–8. 42 indexed citations

10.

Sun, Wen, Jie Yu, Hongwei Gao, et al.. (2018). Inhibition of Lung Cancer by 2-Methoxy-6-Acetyl-7-Methyljuglone Through Induction of Necroptosis by Targeting Receptor-Interacting Protein 1. Antioxidants and Redox Signaling. 31(2). 93–108. 33 indexed citations

11.

Guo, Yanling, Xiaxia Wu, Qin Wu, et al.. (2018). Dihydrotanshinone I, a natural product, ameliorates DSS-induced experimental ulcerative colitis in mice. Toxicology and Applied Pharmacology. 344. 35–45. 50 indexed citations

12.

Yu, Jie, Changxi Wang, Qi Kong, et al.. (2018). Recent progress in doxorubicin-induced cardiotoxicity and protective potential of natural products. Phytomedicine. 40. 125–139. 118 indexed citations

13.

Wu, Xiaxia, et al.. (2018). Neferine, a Bisbenzylisoquinoline Alkaloid, Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis. The American Journal of Chinese Medicine. 46(6). 1263–1279. 27 indexed citations

14.

Sun, Wen, Xiaxia Wu, Hongwei Gao, et al.. (2017). Cytosolic calcium mediates RIP1/RIP3 complex-dependent necroptosis through JNK activation and mitochondrial ROS production in human colon cancer cells. Free Radical Biology and Medicine. 108. 433–444. 116 indexed citations

15.

Wu, Xiaxia, Hongwei Gao, Wen Sun, et al.. (2017). Nepetoidin B, a Natural Product, Inhibits LPS‐stimulated Nitric Oxide Production via Modulation of iNOS Mediated by NF‐κB/MKP‐5 Pathways. Phytotherapy Research. 31(7). 1072–1077. 20 indexed citations

16.

Gao, Hongwei, Wen Sun, Jianping Zhao, et al.. (2016). Tanshinones and diethyl blechnics with anti-inflammatory and anti-cancer activities from Salvia miltiorrhiza Bunge (Danshen). Scientific Reports. 6(1). 33720–33720. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact